Related Experiment Video
Updated: Oct 1, 2026

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
Candida tropicalis and Candida albicans fungemia in children with leukemia
N M Marina1, P M Flynn, G K Rivera
1Department of Hematology-Oncology, St. Jude Children's Research Hospital, Memphis, TN 38101-0318.
Abstract:
The records were reviewed for all patients hospitalized at a pediatric oncology center for complications of leukemia (n = 822) or lymphoma (n = 290) during an 8-year period. The results of surveillance cultures (throat, rectal, and urine) and blood cultures were analyzed to identify cases of Candida tropicalis and C. albicans colonization and/or fungemia. None of the patients with lymphoma who had positive surveillance cultures for C. albicans (n = 89) or C. tropicalis (n = 23) had fungemia. Among patients with leukemia, significant fungal infection was documented in 12 of 107 colonized with C. tropicalis (11.2%) versus 14 of 700 (2%) colonized with C. albicans (P less than 0.001). The two groups of children with fungemia were similar in primary diagnoses (predominantly acute lymphoblastic leukemia) and in the frequency of several known risk factors for infection, including the duration of neutropenia (absolute neutrophil counts, less than 500/microliters). Patients with C. tropicalis fungemia all had disseminated disease compared with nine of 14 patients with C. albicans fungemia. Also, subcutaneous abscesses were unique to patients with C. tropicalis in this series. Two patients in each group died of their infection; central nervous system involvement was present in both fatal cases of C. tropicalis fungemia. A high index of suspicion and the early institution of appropriate antifungal therapy are critical to the successful management of these infections in patients with leukemia.
Insights
Candida tropicalis poses a higher risk of invasive fungal infection and disseminated disease in pediatric leukemia patients compared to Candida albicans. Early antifungal therapy is crucial for managing these serious infections.
Area of Science:
- Infectious Diseases
- Mycology
- Pediatric Oncology
Background:
- Fungal infections, particularly candidemia, are a significant concern in immunocompromised pediatric patients.
- Candida tropicalis and Candida albicans are common causes of fungal infections, but their comparative pathogenicity in specific pediatric populations is not fully elucidated.
Purpose of the Study:
- To compare the incidence and clinical outcomes of Candida tropicalis and Candida albicans colonization and fungemia in pediatric patients with leukemia and lymphoma.
- To identify risk factors and specific clinical manifestations associated with these fungal infections.
Main Methods:
- Retrospective review of surveillance and blood cultures from pediatric oncology patients hospitalized over an 8-year period.
- Analysis of data for patients with leukemia (n=822) and lymphoma (n=290) to identify Candida colonization and fungemia.
Main Results:
- No fungemia occurred in lymphoma patients with positive surveillance cultures for either Candida species.
- Leukemia patients colonized with C. tropicalis had a significantly higher rate of fungemia (11.2%) compared to those colonized with C. albicans (2%) (P < 0.001).
- C. tropicalis fungemia was associated with disseminated disease and subcutaneous abscesses, while central nervous system involvement was noted in fatal cases.
Conclusions:
- Candida tropicalis represents a greater threat for invasive fungal infection and disseminated disease in pediatric leukemia patients than Candida albicans.
- Prompt recognition and aggressive antifungal treatment are essential for improving outcomes in these vulnerable patients.
More Related Videos
Related Concept Videos
Fungal Phylum Microsporidia
Cytomegalovirus Disease
Leishmaniasis
Cryptococcal Meningitis
Candidiasis

